Literature DB >> 15062633

Cognitive impairment in substance abuse.

Peter W Vik1, Tony Cellucci, Amy Jarchow, Jill Hedt.   

Abstract

Conventional wisdom, and even well-reasoned theoretical mechanisms, suggests that the chronic use of psychoactive substances would impair cognitive functioning of individuals. This article summarizes the research literature with regard to specific drugs of abuse. Undoubtedly, acute intoxication and immediate and protracted withdrawal produce transient alterations of cognitions that can persist for weeks to months. Some subtle residual effects remain for up to 1 year for certain drugs. Evidence of irreversible effects is less clear. Even subtle lingering effects can impact treatment efforts, yet they often go undetected or unaddressed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15062633     DOI: 10.1016/S0193-953X(03)00110-2

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  18 in total

1.  Impulsivity in bipolar disorder: relationships with neurocognitive dysfunction and substance use history.

Authors:  Robyn L Powers; Manuela Russo; Katie Mahon; Jesse Brand; Raphael J Braga; Anil K Malhotra; Katherine E Burdick
Journal:  Bipolar Disord       Date:  2013-09-13       Impact factor: 6.744

2.  Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.

Authors:  Marc L Copersino; David J Schretlen; Garrett M Fitzmaurice; Scott E Lukas; Judith Faberman; Jody Sokoloff; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2012-03-26       Impact factor: 3.829

3.  Effects of cigarette smoking and alcohol use on neurocognition and BDNF levels in a Chinese population.

Authors:  Xiang Yang Zhang; Yun-Long Tan; Da-Chun Chen; Shu-Ping Tan; Fu-De Yang; Giovana B Zunta-Soares; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2015-10-30       Impact factor: 4.530

4.  Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders.

Authors:  Brian D Kiluk; Charla Nich; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2010-11-02       Impact factor: 4.492

5.  Neuropsychological functioning in college students who misuse prescription stimulants.

Authors:  Timothy E Wilens; Nicholas W Carrellas; MaryKate Martelon; Amy M Yule; Ronna Fried; Rayce Anselmo; Sean Esteban McCabe
Journal:  Am J Addict       Date:  2017-06

Review 6.  The epidemiology of alcohol consumption and multiple sclerosis: a review.

Authors:  Yu-Jie Wang; Rui Li; Jun-Wei Yan; Ya-Nan Wan; Jin-Hui Tao; Bing Chen; Xiao-Lei Huang; Guo-Jun Yang; Jing Wang; Dong-Qing Ye
Journal:  Neurol Sci       Date:  2014-11-12       Impact factor: 3.307

7.  Performance-Based Contingency Management in Cognitive Remediation Training: A Pilot Study.

Authors:  Brian D Kiluk; Matthew B Buck; Kathleen A Devore; Theresa A Babuscio; Charla Nich; Kathleen M Carroll
Journal:  J Subst Abuse Treat       Date:  2016-08-10

8.  Sex differences in the neurotoxic effects of adenosine A1 receptor antagonism during ethanol withdrawal: reversal with an A1 receptor agonist or an NMDA receptor antagonist.

Authors:  Tracy R Butler; Katherine J Smith; Rachel L Self; Brittany B Braden; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

9.  The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.

Authors:  Marilyn Huckans; Adriana Seelye; Tiffany Parcel; Lisa Mull; Jonathan Woodhouse; Danell Bjornson; Bret E Fuller; Jennifer M Loftis; Benjamin J Morasco; Anna W Sasaki; Daniel Storzbach; Peter Hauser
Journal:  J Int Neuropsychol Soc       Date:  2009-01       Impact factor: 2.892

10.  Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.

Authors:  Roman Shrestha; Elizabeth E DiDomizio; Rayne S Kim; Frederick L Altice; Jeffrey A Wickersham; Michael M Copenhaver
Journal:  J Subst Abuse Treat       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.